Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 93, Issue 3, Pages 437-438Publisher
SPRINGER
DOI: 10.1007/s11060-009-9795-6
Keywords
Paraneoplastic myopathy; Cetuximab; Epidermal growth factor
Categories
Ask authors/readers for more resources
Cetuximab given concurrently with chemotherapy has shown survival benefit for patients with metastatic colon cancer. We report a case of a patient with metastatic colon cancer who developed paraneoplastic necrotizing myopathy that possibly responded to cetuximab despite lack of improvement of the underlying cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
